405MO Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases

Autor: Loupakis, F., Derouazi, M., Murgioni, S., Rizzato, M.D., Sharma, S., Renner, D., Shchegrova, S., Sethi, H., Zimmermann, B., Aleshin, A., Schirripa, M., Munari, G., Tos, A.P. Dei, Lonardi, S., Fassan, M.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S413-S413
Databáze: ScienceDirect